Search clinical trials for: All surgeries performed from Jan 01, 2010 to Aug 31, 2020

Total 13 results

University of Toledo Health Science Campus

Enrolling by invitation

Models for Improving Operating Room Productivity: Delays, Cancellations and Pre-admission Testing

Other Surgical Procedures

United States
University Hospital Inselspital, Berne

Recruiting

Responses to COVID19 Vaccination in Patients With a Treatment History of Rituximab. (RituxiVac)

Immunosuppression | Rituximab | COVID19 Vaccination

Switzerland
Xijing Hospital

Recruiting

The Effect of COVID-19 Infection on Post-operative Complications

COVID-19 | Postoperative Complications | Surgery

China
University of Michigan
National Opinion Research Center

Active, not recruiting

Michigan Contraceptive Access, Research, and Evaluation Study: Phase 1 (M-CARES)

Pregnancy

United States
Prof. Ariane herrick
Versus Arthritis

Completed

Prednisolone in Early Diffuse Systemic Sclerosis (PRedSS)

Systemic Sclerosis

United Kingdom
Institut de Cancérologie de Lorraine

Completed

HCC Response Assessment by MRI After SBRT

Carcinoma, Hepatocellular
Marina Garassino

Unknown

Ramucirumab and Carbo-Paclitaxel for Untreated Thymic Carcinoma / B3 Thymoma With Carcinoma (RELEVENT) (RELEVENT)

Thymic Carcinoma | Thymoma

Italy
R-Pharm

Completed

A Randomized Phase 2 Study of Ixabepilone Plus Carboplatin and Paclitaxel Plus Carboplatin in Advanced Nonsmall-Cell Lung Cancer

Advanced/Metastatic Non-Small Cell Lung Cancer

Germany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
Merck Sharp & Dohme LLC

Completed

Study of Epacadostat (INCB024360) Alone and In Combination With Pembrolizumab (MK-3475) With Chemotherapy and Pembrolizumab Without Chemotherapy in Participants With Advanced Solid Tumors (MK-3475-434)

Neoplasms | Carcinoma, Non-Small-Cell Lung
Hao Long

Recruiting

Predictive Biomarker for Efficacy and Safety of Combination of Chemotherapy and Tislelizumab in NSCLC

Chemotherapy | Safety | Biomarker | Tislelizumab

China
Merck Sharp & Dohme LLC

Completed

Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)

Small Cell Lung Cancer | Solid Tumor | Non-small Cell Lung Cancer
Gilead Sciences

Completed

Safety, Tolerability, Pharmacokinetics and Antiviral Activity of GS-9669 in Subjects With Chronic Hepatitis C Virus Infection

Hepatitis C

United States, Puerto Rico
Pfizer

Completed

Study to Assess Pharmacokinetics, Safety and Tolerability of PF-04965842 in Chinese Healthy Participants

HEALTHY

China

3

Subscribe